Mallinckrodt plc (MNK)

Pharmaceuticals, Biotechnology & Life Sciences

Mallinckrodt plc (MNK) is a global pharmaceutical company that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. The Specialty Brands segment focuses on autoimmune and rare disease treatment in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics. The Specialty Generics and Amitiza segment includes specialty generic drugs, active pharmaceutical ingredients (API) and Amitiza, a leading product in the gastrointestinal market.